Skip to content
healthcare.dev

Inluriyo

NDC 0002-1717, imlunestrant, tablet, film coated, from Eli Lilly and Company.

Product NDC
0002-1717
Status
Listed
Labeler
Eli Lilly and Company
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA218881
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0002-1717 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IMLUNESTRANT200 mg/1

Pharmacologic classes

Breast Cancer Resistance Protein Inhibitors [MoA]; Estrogen Receptor Antagonist [EPC]; Estrogen Receptor Antagonists [MoA]; P-Glycoprotein Inhibitors [MoA]

Package NDCNDC-11Package
0002-1717-280000217172828 TABLET, FILM COATED in 1 BOTTLE (0002-1717-28)
0002-1717-560000217175656 TABLET, FILM COATED in 1 BOTTLE (0002-1717-56)
0002-1717-610000217176156 TABLET, FILM COATED in 1 BOTTLE (0002-1717-61)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5bc172e4-e8a2-441a-be52-279a7f890196

Use it

Look up 0002-1717 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0002-1717 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0002-1717. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.